Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Molecules ; 29(10)2024 May 15.
Article in English | MEDLINE | ID: mdl-38792186

ABSTRACT

Thrombotic disease has been listed as the third most fatal vascular disease in the world. After decades of development, clinical thrombolytic drugs still cannot avoid the occurrence of adverse reactions such as bleeding. A number of studies have shown that the application of various nano-functional materials in thrombus-targeted drug delivery, combined with external stimuli, such as magnetic, near-infrared light, ultrasound, etc., enrich the drugs in the thrombus site and use the properties of nano-functional materials for collaborative thrombolysis, which can effectively reduce adverse reactions such as bleeding and improve thrombolysis efficiency. In this paper, the research progress of organic nanomaterials, inorganic nanomaterials, and biomimetic nanomaterials for drug delivery is briefly reviewed.


Subject(s)
Drug Delivery Systems , Fibrinolytic Agents , Thrombosis , Humans , Fibrinolytic Agents/chemistry , Fibrinolytic Agents/therapeutic use , Fibrinolytic Agents/administration & dosage , Thrombosis/drug therapy , Nanostructures/chemistry , Nanostructures/therapeutic use , Thrombolytic Therapy/methods , Animals
SELECTION OF CITATIONS
SEARCH DETAIL
...